Literature DB >> 33454723

The genetic landscape of polycystic kidney disease in Ireland.

Gianpiero L Cavalleri1, Peter Conlon2,3, Katherine A Benson4, Susan L Murray5, Sarah R Senum6, Elhussein Elhassan5, Eoin T Conlon5, Claire Kennedy5, Shane Conlon5, Edmund Gilbert4, Dervla Connaughton5, Paul O'Hara7, Sarah Khamis4, Sarah Cormican8,9, Lawrence C Brody10, Anne M Molloy11, Sally Ann Lynch12, Liam Casserly7, Matthew D Griffin8,9, Robert Carton4, Kevin Yachnin13, Peter C Harris6.   

Abstract

Polycystic kidney diseases (PKDs) comprise the most common Mendelian forms of renal disease. It is characterised by the development of fluid-filled renal cysts, causing progressive loss of kidney function, culminating in the need for renal replacement therapy or kidney transplant. Ireland represents a valuable region for the genetic study of PKD, as family sizes are traditionally large and the population relatively homogenous. Studying a cohort of 169 patients, we describe the genetic landscape of PKD in Ireland for the first time, compare the clinical features of patients with and without a molecular diagnosis and correlate disease severity with autosomal dominant pathogenic variant type. Using a combination of molecular genetic tools, including targeted next-generation sequencing, we report diagnostic rates of 71-83% in Irish PKD patients, depending on which variant classification guidelines are used (ACMG or Mayo clinic respectively). We have catalogued a spectrum of Irish autosomal dominant PKD pathogenic variants including 36 novel variants. We illustrate how apparently unrelated individuals carrying the same autosomal dominant pathogenic variant are highly likely to have inherited that variant from a common ancestor. We highlight issues surrounding the implementation of the ACMG guidelines for variant pathogenicity interpretation in PKD, which have important implications for clinical genetics.

Entities:  

Mesh:

Year:  2021        PMID: 33454723      PMCID: PMC8110806          DOI: 10.1038/s41431-020-00806-5

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   5.351


  49 in total

1.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering.

Authors:  Sharon R Browning; Brian L Browning
Journal:  Am J Hum Genet       Date:  2007-09-21       Impact factor: 11.025

2.  Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.

Authors:  Sandro Rossetti; Katharina Hopp; Robert A Sikkink; Jamie L Sundsbak; Yean Kit Lee; Vickie Kubly; Bruce W Eckloff; Christopher J Ward; Christopher G Winearls; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 3.  Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Authors:  Emilie Cornec-Le Gall; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

4.  Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Authors:  Riccardo Magistroni; Ning He; Kairong Wang; Robin Andrew; Ann Johnson; Patricia Gabow; Elizabeth Dicks; Patrick Parfrey; Roser Torra; Jose L San-Millan; Eliecer Coto; Marjan Van Dijk; Martijn Breuning; Dorien Peters; Nadja Bogdanova; Giulia Ligabue; Alberto Albertazzi; Nick Hateboer; Kyproula Demetriou; Alkis Pierides; Constantinos Deltas; Peter St George-Hyslop; David Ravine; York Pei
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

5.  Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.

Authors:  Mihailo Vujic; Christina M Heyer; Elisabet Ars; Katharina Hopp; Arseni Markoff; Charlotte Orndal; Bengt Rudenhed; Samih H Nasr; Vicente E Torres; Roser Torra; Nadja Bogdanova; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

6.  Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.

Authors:  Mark B Consugar; Wai C Wong; Patrick A Lundquist; Sandro Rossetti; Vickie J Kubly; Denise L Walker; Laureano J Rangel; Richard Aspinwall; W Patrick Niaudet; Seza Ozen; Albert David; Milen Velinov; Eric J Bergstralh; Kyongtae T Bae; Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Julian R Sampson; Brian D Dawson; Peter C Harris
Journal:  Kidney Int       Date:  2008-09-24       Impact factor: 10.612

7.  Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.

Authors:  Marie-Pierre Audrézet; Christine Corbiere; Said Lebbah; Vincent Morinière; Françoise Broux; Ferielle Louillet; Michel Fischbach; Ariane Zaloszyc; Sylvie Cloarec; Elodie Merieau; Véronique Baudouin; Georges Deschênes; Gwenaelle Roussey; Sandrine Maestri; Chiara Visconti; Olivia Boyer; Carine Abel; Annie Lahoche; Hanitra Randrianaivo; Lucie Bessenay; Djalila Mekahli; Ines Ouertani; Stéphane Decramer; Amélie Ryckenwaert; Emilie Cornec-Le Gall; Rémi Salomon; Claude Ferec; Laurence Heidet
Journal:  J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 14.978

8.  Detecting PKD1 variants in polycystic kidney disease patients by single-molecule long-read sequencing.

Authors:  Daniel M Borràs; Rolf H A M Vossen; Michael Liem; Henk P J Buermans; Hans Dauwerse; Dave van Heusden; Ron T Gansevoort; Johan T den Dunnen; Bart Janssen; Dorien J M Peters; Monique Losekoot; Seyed Yahya Anvar
Journal:  Hum Mutat       Date:  2017-05-29       Impact factor: 4.878

9.  Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families.

Authors:  Vilma Mantovani; Sofia Bin; Claudio Graziano; Irene Capelli; Raffaella Minardi; Valeria Aiello; Enrico Ambrosini; Carlotta Pia Cristalli; Alessandro Mattiaccio; Milena Pariali; Sara De Fanti; Flavio Faletra; Enrico Grosso; Rachele Cantone; Elena Mancini; Francesca Mencarelli; Andrea Pasini; Anita Wischmeijer; Nicola Sciascia; Marco Seri; Gaetano La Manna
Journal:  Front Genet       Date:  2020-05-07       Impact factor: 4.599

10.  Insular Celtic population structure and genomic footprints of migration.

Authors:  Ross P Byrne; Rui Martiniano; Lara M Cassidy; Matthew Carrigan; Garrett Hellenthal; Orla Hardiman; Daniel G Bradley; Russell L McLaughlin
Journal:  PLoS Genet       Date:  2018-01-25       Impact factor: 5.917

View more
  2 in total

1.  Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.

Authors:  Sarah R Senum; Ying Sabrina M Li; Katherine A Benson; Giancarlo Joli; Eric Olinger; Sravanthi Lavu; Charles D Madsen; Adriana V Gregory; Ruxandra Neatu; Timothy L Kline; Marie-Pierre Audrézet; Patricia Outeda; Cherie B Nau; Esther Meijer; Hamad Ali; Theodore I Steinman; Michal Mrug; Paul J Phelan; Terry J Watnick; Dorien J M Peters; Albert C M Ong; Peter J Conlon; Ronald D Perrone; Emilie Cornec-Le Gall; Marie C Hogan; Vicente E Torres; John A Sayer; Peter C Harris
Journal:  Am J Hum Genet       Date:  2021-12-09       Impact factor: 11.043

2.  Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD).

Authors:  Ronald D Perrone; Kaleab Z Abebe; Terry J Watnick; Andrew D Althouse; Kenneth R Hallows; Christina M Lalama; Dana C Miskulin; Stephen L Seliger; Cheng Tao; Peter C Harris; Kyongtae Ty Bae
Journal:  Kidney Int       Date:  2021-06-27       Impact factor: 18.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.